Parkinson's disease or Parkinson's diseases ?AGID, Y.Biomedicine & pharmacotherapy. 1999, Vol 53, Num 7, pp 301-302, issn 0753-3322Article

De la posture à l'initiation du mouvementn, réunuion neurologique internationale, Paris, 1-2 Juin 1989AGID, Y.Revue neurologique (Paris). 1990, Vol 146, Num 10, pp 535-638, issn 0035-3787, 104 p.Conference Proceedings

Troubles obsessionnels compulsifs et neurochirurgie = Obsessional compulsive disorders and neurosurgeryAGID, Y.La Lettre du neurologue. 2005, Vol 9, Num 6, pp 198-200, issn 1276-9339, 3 p.Article

Une façon d'examiner un patient parkinsonien = A way to examine the parkinsonian patientAGID, Y.Revue neurologique (Paris). 2000, Vol 156, Num 1, pp 17-22, issn 0035-3787Article

Levodopa : Is toxicity a myth?AGID, Y.Neurology. 1998, Vol 50, Num 4, pp 858-863, issn 0028-3878Article

Continuous high frequency stimulation of deep brain structures in brain pathologyAGID, Y.Brain research bulletin. 1999, Vol 50, Num 5-6, issn 0361-9230, p. 475Article

De la posture à l'initiation du mouvement = From posture to initiation of movementAGID, Y.Revue neurologique (Paris). 1990, Vol 146, Num 10, issn 0035-3787, p. 535Conference Paper

LES RECEPTEURS DE L'ACETYLCHOLINEKATO G; AGID Y.1979; NOUV. PRESSE MED.; FRA; DA. 1979; VOL. 8; NO 29; PP. 2407-2411; ABS. ENG; BIBL. 23 REF.Article

IS THE MESOCORTICAL DOPAMINERGIE SYSTEM INVOLVED IN PARKINSON DISEASE.JAVOY AGID F; AGID Y.1980; NEUROLOGY; ISSN 0028-3878; USA; DA. 1980; VOL. 30; NO 12; PP. 1326-1330; BIBL. 36 REF.Article

LE SYSTEME DOPAMINERGIQUE MESOCORTICAL EST-IL IMPLIQUE DANS LA MALADIE DE PARKINSON.JAVOY AGID F; AGID Y.1979; REV. NEUROL.; FRA; DA. 1979; VOL. 135; NO 10; PP. 734Article

LABELED WHEAT GERM AGGLUTININ (WGA) AS A NEW, HIGHLY SENSITIVE RETROGRADE TRACER IN THE RAT BRAIN HIPPOCAMPALSYSTEM.SCHWAB ME; JAVOY AGID F; AGID Y et al.1978; BRAIN RES.; NLD; DA. 1978; VOL. 152; NO 1; PP. 145-150; BIBL. 38 REF.Article

EFFECT OF A METHIONINE-ENKEPHALIN ANALOG IN HUNTINGTON'S DISEASEAGID Y; DESTEE A; LALLEMAND A et al.1983; ADVANCES IN NEUROLOGY; ISSN 0091-3952; USA; DA. 1983; VOL. 37; PP. 299-304; BIBL. 21 REF.Article

MICROTOPOGRAPHY OF TYROSINE HYDROXYLASE, GLUTAMIC ACID DECARBOXYLASE, AND CHOLINE ACETYLTRANSFERASE IN THE SUBSTANTIA NIGRA AND VENTRAL TEGMENTAL AREA OF CONTROL AND PARKINSONIAN BRAINSJAVOY AGID F; PLOSKA A; AGID Y et al.1981; J. NEUROCHEM.; ISSN 0022-3042; GBR; DA. 1981; VOL. 37; NO 5; PP. 1218-1227; BIBL. 2 P.Article

Maladie de Parkinson : mécanismes de la mort cellulaire = Parkinson's disease: cell death mechanismsMICHEL, P.-P; HIRSCH, E.-C; AGID, Y et al.Revue neurologique (Paris). 2002, Vol 158, Num 12, pp 7S24-7S32, issn 0035-3787, HS1Article

Les fluctuations = On-off fluctuationsDAMIER, Ph.Revue neurologique (Paris). 2002, Vol 158, Num 12, pp 7S85-7S91, issn 0035-3787, HS1Article

Maladie de Parkinson : stimulation cérébrale profonde = Parkinson's disease: deep brain stimulationKRACK, P.Revue neurologique (Paris). 2002, Vol 158, Num 12, pp 7S135-7S141, issn 0035-3787, HS1Article

TRAITEMENT D'UN ETAT HALLUCINOSIQUE AVEC HYPERSOMNIE DIURNE PAR L'ACIDE OXOLINIQUELHERMITTE F; SIGNORET JL; AGID Y et al.1978; NOUV. PRESSE MED.; FRA; DA. 1978; VOL. 7; NO 43; PP. 3936; BIBL. 3 REF.Article

SPECIFICITY OF DOPAMINERGIC NEURONAL DEGENERATION INDUCED BY INTRACEREBRAL INJECTION OF 6-HYDROXYDOPAMINE IN THE NIGROSTRIATAL DOPAMINE SYSTEM = SPECIFICITE DE LA DEGENERESCENCE DES NEURONES DOPAMINERGIQUES INDUIT PAR INJECTION INTRACEREBRALE DE 6 HYDROXYDOPAMINE DANS LE SYSTEME DOPAMINERGIQUE LOCUS NIGER-STRIATUMJAVOY F; SOTELO C; HERBET A et al.1976; BRAIN RES.; NETHERL.; DA. 1976; VOL. 102; NO 2; PP. 201-215; BIBL. 1 P.Article

FEEDBACK CONTROL OF DOPAMINE SYNTHESIS IN DOPAMINERGIC TERMINALS OF THE RAT STRIATUMJAVOY F; AGID Y; BOUVET D et al.1972; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1972; VOL. 182; NO 3; PP. 454-463; BIBL. 24 REF.Serial Issue

Fluctuations motrices = Motor fluctuationsDURIF, F.Revue neurologique (Paris). 2002, Vol 158, Num 12, pp 7S111-7S116, issn 0035-3787, HS1Article

Greffes neuronales et maladie de Parkinson = Treatment of Parkinson's disease by cell transplantationCESARO, P.Revue neurologique (Paris). 2002, Vol 158, Num 12, pp 7S142-7S143, issn 0035-3787, HS1Article

Levodopa: Is toxicity a myth?AGID, Y.Neurology. 2001, Vol 57, Num 10, pp S46-S51, issn 0028-3878, SUP3Article

THYROTROPIN RELEASING HORMONE CONTENT IS UNCHANGED IN BRAINS OF PATIENTS WITH PARKINSON DISEASEJAVOY AGID F; GROUSELLE D; TIXIER VIDAL A et al.1983; NEUROPEPTIDES (EDINBURGH); ISSN 0143-4179; GBR; DA. 1983; VOL. 3; NO 5; PP. 405-410; BIBL. 14 REF.Article

EFFET D'UN ANALOGUE SYNTHETIQUE DE L'ENKEPHALINE DANS LE SYNDROME CHOREIQUEDESTEE A; PETIT H; WAROT P et al.1982; REVUE NEUROLOGIQUE; ISSN 0035-3787; FRA; DA. 1982; VOL. 138; NO 11; PP. 845-849; ABS. ENG; BIBL. 24 REF.Article

BROMOCRIPTINE AND DOMPERIDONE IN THE TREATMENT OF PARKINSON DISEASEQUINN N; ILLAS A; LHERMITTE F et al.1981; NEUROLOGY; ISSN 0028-3878; USA; DA. 1981; VOL. 31; NO 6; PP. 662-667; BIBL. 19 REF.Article